Faheem Hasnain

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Faheem Hasnain:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gossamer Bio, Inc. President & CEO, Director Common Stock 5,408,073 $19,577,224 $3.62 02 Jan 2026 By family trust
Gossamer Bio, Inc. President & CEO, Director Common Stock 837,793 $3,032,810 $3.62 02 Jan 2026 Direct
Kura Oncology, Inc. Director Common Stock 23,983 $263,247 $10.98 09 Dec 2025 Direct
Gossamer Bio, Inc. President & CEO, Director Stock Option (Right to Buy) 1,680,000 02 Jan 2026 Direct
Kura Oncology, Inc. Director Option to purchase common stock 28,500 05 Jun 2025 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 23 Jan 2024 Direct

Insider Reports Filed by Faheem Hasnain

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GOSS Gossamer Bio, Inc. 02 Jan 2026 2 $0 4 President & CEO, Director 05 Jan 2026, 16:40
KURA Kura Oncology, Inc. 09 Dec 2025 2 -$78,564 4 Director 10 Dec 2025, 16:05
GOSS Gossamer Bio, Inc. 01 Oct 2025 1 $0 4 President & CEO, Director 02 Oct 2025, 16:13
KURA Kura Oncology, Inc. 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
KURA Kura Oncology, Inc. 21 Mar 2025 2 -$38,106 4 Director 24 Mar 2025, 16:33
GOSS Gossamer Bio, Inc. 04 Mar 2025 1 $0 4 President & CEO, Director 06 Mar 2025, 16:03
GOSS Gossamer Bio, Inc. 21 Jun 2024 1 +$250,282 4 President & CEO, Director 24 Jun 2024, 17:52
KURA Kura Oncology, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:30
GOSS Gossamer Bio, Inc. 27 Mar 2024 1 -$26,773 4 President & CEO, Director 28 Mar 2024, 18:01
/report/000114036124003533-hasnain-faheem-2024-01-23 Mirati Therapeutics, Inc. 23 Jan 2024 6 $0 4 Director 23 Jan 2024, 20:37
GOSS Gossamer Bio, Inc. 02 Jan 2024 1 $0 4 President & CEO, Director 04 Jan 2024, 17:00
/report/000162828024000294-hasnain-faheem-2023-12-29 Mirati Therapeutics, Inc. 29 Dec 2023 1 +$569,992 4 Director 03 Jan 2024, 18:18
GOSS Gossamer Bio, Inc. 20 Nov 2023 1 $0 4 President & CEO, Director 22 Nov 2023, 19:07
/report/000120919123045653-hasnain-faheem-2023-08-11 Mirati Therapeutics, Inc. 11 Aug 2023 1 +$299,990 4 Director 14 Aug 2023, 17:41
GOSS Gossamer Bio, Inc. 24 Jul 2023 2 +$1,000,001 4 President & CEO, Director 26 Jul 2023, 16:02
KURA Kura Oncology, Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 16:49
GOSS Gossamer Bio, Inc. 05 May 2023 1 $0 4 President & CEO, Director 09 May 2023, 16:12
GOSS Gossamer Bio, Inc. 20 Mar 2023 4 +$1,000,389 4 President & CEO, Director 22 Mar 2023, 17:14
/report/000121465923001046-hasnain-faheem-2023-01-20 Mirati Therapeutics, Inc. 20 Jan 2023 2 $0 4 Director 24 Jan 2023, 15:17
GOSS Gossamer Bio, Inc. 07 Dec 2022 1 $0 4 President & CEO, Director 09 Dec 2022, 16:13
GOSS Gossamer Bio, Inc. 15 Jul 2022 1 +$999,998 4 President & CEO, Director 15 Jul 2022, 16:21
KURA Kura Oncology, Inc. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:44
GOSS Gossamer Bio, Inc. 23 Mar 2022 1 -$169,697 4 President & CEO, Director 24 Mar 2022, 16:55
/report/000121465922000854-hasnain-faheem-2022-01-14 Mirati Therapeutics, Inc. 14 Jan 2022 2 $0 4 Director 18 Jan 2022, 19:32
GOSS Gossamer Bio, Inc. 06 Jan 2022 1 $0 4 President & CEO, Director 10 Jan 2022, 15:03
KURA Kura Oncology, Inc. 22 Jun 2021 1 $0 4 Director 23 Jun 2021, 17:15